山東高速(600350.SH)合作發起設立暢贏慧通基金
格隆匯10月24日丨山東高速(600350.SH)公佈,公司全資子公司山東高速投資發展有限公司(以下簡稱“投資公司”)擬與公司子公司山東高速暢贏股權投資管理有限公司(以下簡稱“暢贏公司”)、劉尊亞(自然人)合作發起設立山高暢贏慧通股權投資基金合夥企業(有限合夥)(暫定名,以工商核准為準。以下簡稱“暢贏慧通基金”)。
投資公司作為有限合夥人認繳出資2.4738億元,出資佔比50.49%;劉尊亞作為有限合夥人認繳出資2.4252億元,出資佔比49.49%;暢贏公司作為普通合夥人認繳出資10萬元,出資佔比0.02%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.